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Recent observations (1-3) made in several laboratories have implied structural
and functional analogies between the cytolysis produced by complement and by
lymphocytes. Cell damage produced in both instances appears to involve func-
tional pore formation on the surfaceoftargets. The membranedamagemediated
by C involves the macromolecular assembly of the membrane attack complex
(MAC), with association ofthe five terminal C components, namely C5b, C6, C7,
C8, and C9 (4-6). C9 is the protein thought to be largely responsible for the
formation ofthe ring-like lesions previously associated with the MAC (7). In the
case of CTL and NK cells, a granule pore-forming protein (PFP, perforin or
cytolysin) has been implicated in lymphocyte-mediated cell killing (1-3). The
immunological similarity betweenC9and PFPwasrecently assessed using specific
antibodies (8-10). Human C9 is immunologically related to PFP isolated from
mouse CTL (8), human peripheral blood large granular lymphocytes (9), and
NK cells (10). We report here on immunological similarities between mouse
lymphocyte PFP and other C components of MAC.
Materials and Methods
BriefDefinitive Report
Purified C Components.
￿
C5b-6 (11), C7 (12), C8 (13), and C9 (14) were purified from
outdated human serum (N .Y. Blood Center) according to published procedures. The
homogeneity of purified C components was ascertained by SDS-gel electrophoresis (Fig.
1). In some experiments, commercially available C components (Calbiochem-Behring
Corp., La Jolla, CA) were also used. The gel profile of the commercially obtained C
components was comparable to that shown in Fig. 1 .
Purified Lymphocyte PFP/Perforin. The mouse cytotoxic T cell line CTLL-R8 was
maintained as previously described (15). Isolation ofgranules and PFP/perforin followed
published procedure given elsewhere (16).
Polyclonal Antisera. Antisera against C5b-6, C7, C8, C9, and PFP/perforin were
generated by multiple injections of antigens (10-30 ug, boiled in 1% SDS) into rabbits
following the scheme outlined elsewhere (8, 17). Reduced and alkylated antigens were
prepared as described (8).
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FIGURE 1 .
￿
SDS-gel profile or purified components of human C . 10 Pg ofprotein was applied
per lane .
Gel Electrophoresis and Immunoblotting .
￿
Protein samples in 1% SDS were reduced and
alkylated with 50 mM DTT and 100 mM iodoacetamide (8) . After boiling for 5 min, the
samples were applied to 20-cm gradient-gel slabs of 4-11% polyacrylamide, which were
developed according to Laemmli (18), and stained with Coomassie Brilliant Blue .
Immunoblots were developed using mini-gels (Model 360, Bio-Rad Laboratories, Rich-
mond, CA) with gradient polyacrylamide of 4-20%, followed by electrotransfer ofproteins
to nitrocellulose membranes at a constant 400 mA for 2.5 h (19) . Membranes were
blocked with 1% milk, 2% glycine in Tris-buffered saline for 5 h at 37°C . Antisera were
used at a dilution of 1 :50, and goat ...I-F(ab')z anti-rabbit IgG (5 .6 IACi/wg ; New England
Nuclear, Boston, MA) was used as the secondary label at 0.12 ACi/ml . Membranes were
washed with 20 mM Tris-buffer, pH 7 .4, containing 0 .4 M NaCl, 0.25% Tween-20 (Bio-
Rad Laboratories), 0.25% NP-40 (Calbiochem-Behring Corp .), and 2 mM EDTA . Auto-
radiography was performed for 8-16 h with intensifying screens . The M,. standards used
for regular gels were obtained from Sigma Chemical Co . (St . Louis, MO) and for the blots
consisted of prestained protein markers obtained from Bethesda Research Laboratories
(Gaithersburg, MD) .
Results
Immunological Crossreactivity between PFP/Perforin and C Components . The
Immunological similarities between lymphocyte PFP/perforin and various com-
ponents of human C MAC were assessed by immunoblot, using polyclonal
antibodies specific for each component . Purified mouse lymphocyte PFP/per-
forin reacted on immunoblots with each of the antibodies raised against C5b-6,
C7, C8, or C9 (Fig . 2A) . We observed crossreactivity only when PFP/perforin
was reduced and when anti-C antibodies were raised against reduced and alkyl-
ated antigens . Human C components that were boiled in 1 % SDS but that were
not reduced did not elicit crossreactive antibodies when used as immunogens
(Fig . 2A) .
Immunological Crossreactivity between the Different C Components .
￿
As expected,
antisera raised against C5b-6, C7, and C8 also reacted with C9 (Fig . 2B) .
Conversely, anti-C9 antibodies reacted with C5b-6, C7, and C8a (Fig . 3) . 1nYOUNG ET AL .
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FIGURE 2 .
￿
Immunoblot of mousePFP/perforin and C9 using anti-C and anti-PFP antibodies .
Reduced and alkylated forms of purified PFP/perforin (A)and C9 (B) were applied at 0.1 wg
per lane . Immunoblots were developed with antisera specific for thenonreduced form of PFP
(A, lane 1), and the reduced forms of C5b-6 (A, 2and B, 1), C7 (A, 3 and B, 2), C8 (A, 4 and
B, 3),C9 (A, 5and B, 4) . (A) lanes 6-9and (B) lanes 5-8were reacted with antisera specific for
nonreduced forms of C5b-6 (A, 6and B, 5), C7 (A, 7and B, 6), C8 (A, 8and B, 7),andC5b-6
(A, 9 and B, 8) . (A) lanes 10-18 (B) lanes 9-16 correspond to immunoblots developed under
similar conditions with the respective preimmune sera in the sequence mentioned above.
Autoradiography was performed for 16h.
FIGURE 3 .
￿
Immunological crossreactivities between human C components of MAC. C5b-6
(lanes 1, 5, 9, and 13), C7 (lanes 2, 6, 10, and 14), andC8 (lanes 3, 7, 11, and 15) were applied
at 2 ag per lane . 0.5 Ag of C9 was applied to lanes 4, 8, 12, and 16 . Lanes 1-4were developed
with antisera specific for reduced and alkylated C9 . Lanes 5-8 were reacted with antisera
raised against the nonreduced form of C9 boiled in 1% SDS . Lanes 9-16 correspond to
reaction with respective preimmune antisera in the sequence mentionedabove .The x-ray film
wasexposed for 16 h . Lanes 1 and 9 were exposed for 48 h .
experiments using up to 2 Ag of C5b-6 per lane and exposure of the autoradi-
ogram for 48 h, only C6 reacted with anti-C9 antibodies (Fig . 3) . However, on
longer exposures (7 d), anti-C9 antibodies also reacted weakly with C5b (75-
kD) (not shown) . Immunoblots developed under similar conditions did not react
with the preimtnune serum . The crossreactivity observed here between C com-2080
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ponents was also only observed when the reactive antigens and the immunogens
used to elicit antibodies were reduced and alkylated (Figs. 2B and 3) . These
results indicate that the crossreactivity observed between the different compo-
nents of C MAC and PFP/perforin is restricted to cysteine-rich domains which
are normally masked by disulfide bridges and become antigenically exposed only
upon chemical reduction.
Discussion
Antibodies prepared against target cell membranes damaged by lymphocytes
have previously been shown (20, 21) to crossreact with C proteins. However, the
identity of the crossreactive proteins and the extent of the immunological
crossreactivity were not determined in those studies. Recent results (8-10) have
shown that C9 and PFP/perforin display structural, immunological, and func-
tional similarities. Both species have been shown to undergo polymerization to
form circular lesions. The results presented in this report extend these observa-
tions by showing that the lymphocyte PFP/perforin is also immunologically
related to C5b-6, C7, and C8 . The antigenic epitope(s) shared by mouse lympho-
cyte PFP and human MAC is restricted to cysteine-rich domain(s). These regions
are thought to be exposed after major structural rearrangement of the proteins,
which presumably occurs after membrane insertion and polymerization. It may
be noteworthy to point out that the primary sequence of human C9, recently
deduced by molecular cloning (22, 23), contains cysteine-rich domains that show
extensive homologies to the low-density lipoprotein (LDL) receptor. It is possible
that the same cysteine-rich region(s) are present in other components of MAC
and in lymphocyte PFP/perforin . The function of these highly conserved do-
mains remains unclear. In the case of LDL receptor they are thought to be
involved in ligand binding (24). A similarly important function might be played
by homologous domainsof C components and lymphocyte PFP in the attachment
of these proteins to lipid membranes and/or in their subsequent pore formation.
The results presented here further support and extend the notion of "comple-
ment supergenes" previously proposed for C6 and C7 (25, 26). On the basis of
structural and functional similarities, a genetic relationship has also been pro-
posed for several other complement proteins, including Clr and Cls; C3, C4, and
C5; C2 and factor B (reviewed in reference 27). The observed immunological
similarities between lymphocyte PFP/perforin and several C components provide
a structural basis for theanalogies observed between C and lymphocyte-mediated
cell killing.
While this manuscript was in preparation, Tschopp et al. reported (28) that
antibodies raised against a synthetic peptide prepared to mimic a region of
homology between C9 and LDL receptor also react against other C components
and lymphocyte PFP/perforin.
Summary
Structural, functional and immunological similarities between the ninth com-
ponent of complement (C9) and the lymphocyte pore-forming protein (PFP,
perforin) have recently been described (8-10). PFP is shown here to be immu-
nologically related to all other components of the membrane attack complexYOUNG ET AL .
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(MAC) of human complement, namely, C5b-6, C7, C8, and C9. Polyclonal
antibodies raised against purified human C5b-6, C7, C8, or C9 react with other
components of the MAC and with mouse lymphocyte PFP. The antigenic
epitopes shared by human complement proteins and mouse lymphocyte PFP are
limited to cysteine-rich domains. Only complement proteins that have been
reduced and alkylated elicit the production ofcrossreactive antibodies when used
as immunogens. The nonreduced forms of complement components or lympho-
cyte PFP neither react with these antibodies nor give rise to crossreactive
antibodies. The homologous domains of complement proteins and lymphocyte
PFP may play related functions in their attachment to lipid membranes and
assembly of membrane lesions.
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